These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17205194)

  • 21. The 22q11.2 deletion syndrome.
    Emanuel BS; McDonald-McGinn D; Saitta SC; Zackai EH
    Adv Pediatr; 2001; 48():39-73. PubMed ID: 11480765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
    Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
    Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deconstructing DiGeorge syndrome.
    Schinke M; Izumo S
    Nat Genet; 2001 Mar; 27(3):238-40. PubMed ID: 11242098
    [No Abstract]   [Full Text] [Related]  

  • 24. [Phenotypic and genotypic analysis of a fetus carrying an intermediate 22q11.2 deletion encompassing the CRKL gene].
    Lin S; Zheng X; Gu H; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):393-397. PubMed ID: 28604963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome.
    Meechan DW; Maynard TM; Wu Y; Gopalakrishna D; Lieberman JA; LaMantia AS
    Mol Cell Neurosci; 2006 Dec; 33(4):412-28. PubMed ID: 17097888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advance of research on 22q11.2 deletion syndrome].
    Zhou H; Weng X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug; 41(8):994-1000. PubMed ID: 39097286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of genes outside the deleted region in individuals with 22q11.2 deletion syndrome.
    Dantas AG; Santoro ML; Nunes N; de Mello CB; Pimenta LSE; Meloni VA; Soares DCQ; Belangero SN; Carvalheira G; Kim CA; Melaragno MI
    Hum Genet; 2019 Jan; 138(1):93-103. PubMed ID: 30627818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible mechanisms and gene involvement in speech problems in the 22q11.2 deletion syndrome.
    Widdershoven JC; Beemer FA; Kon M; Dejonckere PH; Mink van der Molen AB
    J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1016-23. PubMed ID: 18554997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting contiguous gene defects: TBX1.
    Baldini A
    Curr Opin Genet Dev; 2005 Jun; 15(3):279-84. PubMed ID: 15917203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chromosome 22q11 and schizophrenia].
    Agatsuma S; Hiroi N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Apr; 25(2):79-84. PubMed ID: 16220657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DiGeorge syndrome: the use of model organisms to dissect complex genetics.
    Baldini A
    Hum Mol Genet; 2002 Oct; 11(20):2363-9. PubMed ID: 12351571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes.
    Meechan DW; Maynard TM; Tucker ES; LaMantia AS
    Int J Dev Neurosci; 2011 May; 29(3):283-94. PubMed ID: 20833244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments.
    Paylor R; McIlwain KL; McAninch R; Nellis A; Yuva-Paylor LA; Baldini A; Lindsay EA
    Hum Mol Genet; 2001 Nov; 10(23):2645-50. PubMed ID: 11726551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 22q11 deletion syndrome: is that what they used to call . . . ?
    Umlauf MG
    Perspect Psychiatr Care; 2008 Oct; 44(4):259-66. PubMed ID: 18826464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TBX1 protein interactions and microRNA-96-5p regulation controls cell proliferation during craniofacial and dental development: implications for 22q11.2 deletion syndrome.
    Gao S; Moreno M; Eliason S; Cao H; Li X; Yu W; Bidlack FB; Margolis HC; Baldini A; Amendt BA
    Hum Mol Genet; 2015 Apr; 24(8):2330-48. PubMed ID: 25556186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels.
    Karbarz M
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32842603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of a zinc finger gene consistently deleted in DiGeorge syndrome.
    Aubry M; Demczuk S; Desmaze C; Aikem M; Aurias A; Julien JP; Rouleau GA
    Hum Mol Genet; 1993 Oct; 2(10):1583-7. PubMed ID: 8268910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical presentations of 22q11.2 deletion syndrome: explaining the genetic defects and genome architecture.
    Tuţulan-Cuniţă AC; Budişteanu M; Papuc SM; Dupont JM; Blancho D; Lebbar A; Viot G; Lungeanu A; Arghir A
    Psychiatry Res; 2012 May; 197(3):356-7. PubMed ID: 22365273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.